INCREASED WAITING TIME FOR LIVER-TRANSPLANTATION RESULTS IN HIGHER MORTALITY

Citation
Je. Everhart et al., INCREASED WAITING TIME FOR LIVER-TRANSPLANTATION RESULTS IN HIGHER MORTALITY, Transplantation, 64(9), 1997, pp. 1300-1306
Citations number
10
Categorie Soggetti
Immunology,Surgery,Transplantation
Journal title
ISSN journal
00411337
Volume
64
Issue
9
Year of publication
1997
Pages
1300 - 1306
Database
ISI
SICI code
0041-1337(1997)64:9<1300:IWTFLR>2.0.ZU;2-#
Abstract
Background. Waiting time to liver transplantation (LTx) has dramatical ly lengthened, but the proportion of candidates who die awaiting trans plantation has not increased, We evaluated whether longer waiting time for LTx candidates increases mortality, Methods. A cohort of candidat es listed for LTx between 1990 and 1993 by three large transplantation programs was followed for 2 years, The exposure measure was ABO blood type, which is not inherently related to outcome, but is a major dete rminant of waiting time, The main outcome measure was a-year mortality , as evaluated by logistic regression analysis that controlled for dif ferences in clinical status at the time of evaluation for LTx. Results ., The 308 candidates with type O blood waited longer for LTx (median 109 days) than the 399 candidates with other blood types (median 58 da ys) (P=0.001), Candidates listed for LTx with type O blood had better clinical status at evaluation, but then had higher pretransplantation mortality (13.3%) than other candidates (7.0%) (P=0.005). Blood group O candidates had higher a-year mortality (26.6%) than other candidates (22.1%), which on multivariate analysis resulted in a mortality odds ratio at 2 years of 1.52 (95% confidence interval=1.04-2.23). With the difference in median waiting time between blood groups increasing fro m 44 days in the first year to 108 days in the third year, the a-year mortality odds ratio also rose from 0.94 to 1.97., Conclusions, When c ompared with LTx candidates with other blood types, blood type O candi dates have longer waiting times and higher pretransplantation mortalit y, which results in higher a-year mortality.